Health China

View Profile


Peer Reviewed Papers, Books, Chapters

Year Title Citation Authors
1. 2010 NKp46 O-glycan sequences that are involved in the interaction with hemagglutinin type 1 of influenza virus. J Virol. 84(8): 3789-3797. Epub 2010 Feb 10.
2. 2010 Killing of avian and Swine influenza virus by natural killer cells. J Virol. 84(8):3993-4001. Epub 2010 Feb 3.
3. 2010 Inhibitory NK receptor recognition of HLA-G: regulation by contact residues and by cell specific expression at the fetal-maternal interface 2010 PLoS One, Jan 28;5(1):e8941.
4. 2010 The NKp46 activating receptor is essential for type 1 diabetes development. Nature Immunology, 11(2), 121-128.
5. 2010 Notch activation enhances IFNγ secretion by human peripheral blood and decidual NK cells The Journal of Reproductive Immunology. 84(1):1-7.
6. 2010 Methods to identify and characterize different NK cell receptors and their ligands. Methods Mol Biol. 612: 249-273.
7. 2010 The human cytomegalovirus microRNA miR-UL112 acts synergistically with a cellular microRNA to escape immune elimination. Nature Immunol. 11(9):806-13. Epub 2010 Aug 8.
8. 2010 Tumor Immunoediting by NKp46. J Immunol. 15;184(10):5637-5644. Epub 2010 Apr 19.
9. 2010 The association of MHC class I proteins with the 2B4 receptor inhibits self-killing of human NK cells. J Immunol. 184(6): 2761-2768. Epub 2010 Feb 17.
10. 2009 The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity. Proc Natl Acad Sci U S A. 106(42): 17858-17863.
11. 2009 Analysis of human cytomegalovirus encoded-microRNAs activity during infection. J Virol. 83(20):10684-10693
12. 2009 Diverse herpesvirus microRNAs target the stress-induced immune ligand MICB to escape recognition by natural killer cells. Cell Host Microbe. 5: 376-385.
13. 2009 An integrated view of NKG2D ligands regulation. Immunology, 128(1): 1-6.
14. 2009 Enhanced in vivo growth of lymphoma tumors in the absence of the NK activating receptor NKp46/NCR1 J. Immunol 182: 2221-2230., 6.068; 13/119; 6:6
15. 2009 The natural cytotoxicity receptor NKp46 is dispensable for IL-22-mediated innate intestinal immune defense against Citrobacter rodentium. J Immunol. 183(10): 6579-6587.
16. 2009 Dynamic behavior of NK cells during activation in lymph nodes. Blood. 114(15): 3227-3234
17. 2008 Harnessing soluble NK cell killer receptors for the generation of novel cancer immune therapy PLoS ONE. 2008 May 14;3(5):e2150. 3.238; 13/37; 2;2
18. 2008 H5-type Influenza Hemagglutinin is Functionally Recognized by the Natural Killer Activating Receptor, NKp44. J Virol. 82: 2028-2032 5.332; 3/25; 2;2
19. 2008 Expression of Ligands to NKp46 in Benign and Malignant Melanocytes J Invest Dermatol. 128: 972-979. 0.28 98/178: 0
20. 2008 Altered Glycosylation of Recombinant NKp30 Hampers Binding to Heparan Sulfate: a Lesson for the Use of Recombinant Immuno-Receptors as an Immunological tool Glycobiology. 18: 28-41. 2.901; 51/119; 0
21. 2008 Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense. Immunity. 29: 958-970.
22. 2008 Human microRNAs regulate stress-induced immune responses mediated by the receptor NKG2D Nature Immunology, 9: 1065-1073. 26.382; 3/263; 20:20
23. 2008 Endometrial Natural Killer Cells are Special Immature Cells that Await Pregnancy J. Immunol, 181: 1869-1876. 6.068; 13/119; 0
24. 2008 Influenza virus infection augments NK cell inhibition through the reorganization of MHC class I proteins JVI, 82: 8030-8037. 5.332; 3/25; 0
25. 2008 Immunological assessment of familial tinea corporis J Eur Acad Dermatol Venereol. 22: 871-874. 1.437; 20/41; 0
26. 2007 Intracellular cysteine residues in the tail of MHC class I proteins are crucial for extracellular recognition by LIR11 J. Immunol, 179: 3655-3661. 6.068; 13/119; 1;1
27. 2007 The unique properties of human NK cells in the uterine mucosa Placenta. 2007 Nov 24; [Epub ahead of print] 3.238; 13/37; 4;4
28. 2007 When killers become helpers Trends Immunol. 28(5): 201-206. 9.480; 7/119; 17;15
29. 2007 A phenotypic and functional characterization of NK cells in adenoids. J Leukoc Biol. 2007 Aug 3; [Epub ahead of print] 4.128; 50/156;
30. 2007 Intercellular transfer of CEA from tumor cells to NK cells J. Immunol, 317: 376-381. 6.068; 13/119; 1;1
31. 2007 Neisserial outer membrane vesicles bind the co-inhibitory receptor CEACAM1 and suppress CD4+ T lymphocyte function Infect Immun. Jul 9; [Epub ahead of print]. 3.996; 28/119; 6.068; 13/119; 6;6
32. 2007 Host immune system gene targeting by a viral miRNA. Science. 317: 376-381. 26.372; 2/50; 61;61
33. 2007 HLA-G complexes are observed on the cell surface Hum Immunol. 68(4): 227-232. 2.901; 51/119; 0
34. 2007 Subcellular localization determines the delicate balance between the anti- and pro-apoptotic activity of Livin Apoptosis. 12(7):1129-1142. 3.003, 60/128; 3;3
35. 2007 NK cytotoxicity mediated by CD16 but not by NKp30 is functional in Griscelli syndrome. Blood 109(10): 4306-4312. Epub 2007 Jan 25. 10.896; 2/63; 5;5
36. 2007 CD11cloB220+ interferon-producing killer dendritic cells are activated natural killer cells J Exp Med. 204: 2569-2478. 15.612; 5/119; 34;34
37. 2007 The Expression Level of Ligands for Natural Killer Cell Receptors Predicts Response to Bacillus Calmette-Guerin Therapy: A Pilot Study J Urol. 178:2660-2664. 4.053; 8/55; 2;2
38. 2007 Manipulation of NK cytotoxicity by the IAP family member Euro J Immunol. 4.812; 52/263; 37:3467-3476. 2;2
39. 2007 CD100 on NK Cells Enhance IFNgamma Secretion and Killing of Target Cells Expressing CD72 PLoS ONE. 2(9): e818. 3.238; 13/37; 1;1
40. 2006 Tumor and viral recognition by natural killer cells receptors. Semin Cancer Biol. 16(5): 348-58 7.510; 11/132; 14;10
41. 2006 Human embryonic stem cells and their differentiated derivatives are less susceptible to immune rejection than adult cells Stem Cells. 24, 221-229. 7.531; 5/138; 78;78
42. 2006 CEACAM1 (CD66a) promotes human monocyte survival via a phosphatidylinositol 3-kinase- and AKT-dependent pathway J Biol Chem. 281(51): 39179-93. 5.581; 40/263; 6;5
43. 2006 Inhibition of human tumor-infiltrating lymphocyte effector functions by the homophilic carcinoembryonic cell adhesion molecule 1 interactions J Immunol. 177(9): 6062-71. 26.218; 3/119; 3;3
44. 2006 Decidual NK Cells Regulate Key Developmental Processes at the Human Maternal-Fetal Interface Nature Medicine. 12: 1065-1074. 26.382; 3/263; 133;127
45. 2006 Lethal influenza infection in the absence of Ncr1 Nature Immunol, 7: 517-523. 26.218; 3/119; 54;47
46. 2006 Reduced KIR2DL1 recognition of MHC class I molecules presenting phosphorylated peptides J Immunol, 176: 6762-6769. 6.068; 13/119; 2;2
47. 2005 Carcinoembryonic antigen (CEA) inhibits NK killing via interaction with CEACAM1 J. Immunol.174, 6692-6701. 6.068; 13/119; 21;16
48. 2005 Is Expressed and Functional on Human Eosinophils. J. Immunol. 174: 110-118. 6.068; 13/119; 23;23
49. 2005 A novel interaction between the HCMV pp65 protein and the NK activating receptor NKp30 leads to a general inhibition of NK killing Nature. Immunol. 6, 515-523. 26.218; 3/119; 63;54
50. 2005 Natural Killer cells and CEACAM1 in Ankylosing Spondylitis Int Immunol. 17, 837-845. 3.290; 43/119; 5;4
51. 2005 The CD85J/leukocyte inhibitory receptor-1 distinguishes between conformed and beta 2-microglobulin-free HLA-G molecules. J. Immunol. 175, 4866-4874. 6.068; 13/119; 24;23
52. 2005 Functional aberrant expression of CCR2 receptor on chronically activated NK cells in patients with TAP-2 deficiency Blood. 106, 3465-3473. 10.896; 2/63; 5;5
53. 2005 Proteomic analysis of human natural killer cells: insights on new potential NK immune functions Mol Immunol. 42: 425-431. 3.742; 79/263; 8;6
54. 2004 Novel APC-like Properties of Human NK Cells Directly Regulate T cell Activation in Health and Disease J. Clin. Invest. 114:1612-1623. 16.915; 2/81; 54;46
55. 2004 Novel Insights on Human Natural Killer Cells Immunological Modalities Revealed by Gene Expression Profiling J. Immunol. 173: 6547-6563; 6.068; 13/119; 38;30
56. 2004 The Critical Role of Residues 43R and 44Q of Carcinoembryonic Antigen Cell Adhesion Molecules-1 in the Protection from Killing by Human NK Cells. J Immunol. 173: 3732-3739; 6.702; 11/114. 15;12
57. 2004 Biological function of the soluble CEACAM1 protein and implications in TAP2-deficient patients. Eur J Immunol.34: 2138-48; 4.662; 19/119; 9;6
58. 2004 MHC class I-independent recognition of the NK activating receptor KIR2DS4 J Immunol. 173: 1819-1825; 6.068; 13/119; 30;29
59. 2004 Recognition of Mycoplasma hyorhinis by CD99-Fc molecule Eur J. Immunol. 34: 2032-2040. 4.662; 19/119; 4;3
60. 2004 Murine B-cell leukemia lymphoma (BCL1) cells as a target for NK cell-mediated immunotherapy Bone Marrow Transplant. 33: 1137-1141. 3.000; 56/132; 4;2
61. 2004 Involvement of the CXCL12/CXCR4 pathway in the advanced liver disease that is associated with hepatitis C virus or hepatitis B virus. Eur J Immunol. 34: 1164-1174. 4.662; 19/119; 17;16
62. 2004 Expression of KIR2DL1 on the entire NK cell population: A possible novel immunodeficiency syndrome Blood. 103:1965-1966 as correspondences to the editor. 10.896; 2/63; 20;19
63. 2004 The Mechanisms Controlling NK Cell Autoreactivity in TAP2-Deficient Patients Blood. 103: 1770-1778. 10.896; 2/63; 29;18
64. 2004 The mechanisms controlling the recognition of tumor and virus infected cells by NKp46 Blood, 103: 664-672. 10.896; 2/63; 49;36
65. 2003 Enhanced recognition of human NK receptors after influenza virus infection J. Immunol. 17: 915-923, 6.068; 13/119; 18;11
66. 2003 Special organization of the HLA-G protein on the cell surface. Human Immunol, 64: 1011-1016, 2.901; 51/119; 13;11
67. 2003 Caspae-mediated cleavage converts livin from an anti-apoptotic to a pro-apoptotic factor: Implications for drug-resistance melanoma Cancer Res. 63: 6340-6349, 7.672; 8/132; 41;39
68. 2003 CXCL12 expression by invasive decidual trophoblasts induces the specific migration of CD16 negative human natural killer cells Blood.102: 1569-1577, 10.896; 2/63; 83;72
69. 2003 Involvement of CXCR4 and IL-2 in the homing and retention of human NK and NK T cells to the bone marrow and spleen of NOD/SCID mice Blood. 102: 1951-1958. 10.896; 2/63;30;28
70. 2003 Soluble non-classical HLA generated by the metalloproteinase pathway Human Immunol. 64: 802-810, 2.901; 51/119; 17;15
71. 2003 Complexes of HLA-G protein on the cell surface are important for leukocyte Ig-like receptor-1 function J. Immunol. 171: 1343-1351, 6.068; 13/119; 33;25
72. 2002 Pivotal role of CEACAM1 protein in the inhibition of activated decidual lymphocyte functions J. Clin. Invest. 110: 943-953. 16.915; 2/81; 46;30
73. 2002 Characterization of the major histocompatibility complex proteins expression in human embryonic stem cells Proc. Natl. Acad. Sci. USA 99: 9864-9869. 9.598; 3/50; 180;180
74. 2002 The NKp46 receptor contributes to NK cell lysis of mononuclear phagocytes infected with an intracellular bacterium. J. Immunol. 168: 3451-3457. 6.068; 13/119; 31;28
75. 2002 CD66a interactions between human melanoma and NK cells: a novel class I MHC-independent inhibitory mechanism of cytotoxicity J. Immunol. 168: 2803-2810. 6.068; 13/119; 58;41
76. 2002 Recruitment of MHC Class I Molecules by Tapasin into the Transporter Associated with Antigen Processing-Associated Complex Is Essential for Optimal Peptide Loading J Immunol. 168: 1950-1960, 6.068; 13/119; 46;46
77. 2001 Recognition of viral hemagglutinins by NKp44 but not by NKp30 Eur.J.Immunol. 31: 2680-2689, 4.662; 19/119; 91;75
78. 2001 Recognition of HLA-Cw4 but not HLA-Cw6 by the NK cell receptor killer cell Ig-like receptor two-domain short tail number 4 J. Immunol, 166: 7260-7267, 6.068; 13/119; 41;27
79. 2001 Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human natural killer cells Nature. 409: 1055-1060, 28.751; 1/50; 240;206
80. 2001 Molecules in focus: NKp46 Int J Biochem Cell Biol. 33, 1147-1150. 4.009; 67/263; 12;9
81. 2000 N-linked carbohydrate on human leukocyte (HLA)-C and recognition by natural killer cell inhibitory receptors Human Immunol. 61: 1202-1218. 2.901; 51/119; 8;7
82. 2000 The role of NK cells in innate immunity. Adv. Exp. Med. Biol, 479, 137-145; 3; 3. 5;3
83. 1999 Human CD16 as a lysis receptor mediating direct natural killer (NK) cell cytotoxicity. Proc. Natl. Acad. Sci USA. 96: 5640-5644. 9.598; 3/50; 73; 53
84. 1999 The selective downregulation of class I major histocompatibility proteins by HIV-I protects HIV-infected cells from NK cells Immunity, 10: 661-672, 19.266; 4/119; 323;314
85. 1999 The transmembrane sequence of human leukocyte antigen (HLA-) C as a determinant in inhibition of a subset of natural killer cells J. Exp. Med. 189: 1265-1274. 15.612; 5/119; 16;11
86. 1999 The human natural killer cell immune synapse Proc. Natl. Acad. Sci., 96: 15062-15067, 9.598; 3/50; 162;158
87. 1999 Tumor variability and sensitivity to T and NK cells: implications for cancer immunotherapy. K. Kikuchi, B.J. Van den Eynde, and N. Sato (eds.); Recent advances of human tumor immunology and immunotherapy. Gann Monograph on Cancer Research, 48: 105-116, Basel, Karger, Sept
88. 1999 HLA-G and its recognition by NK cells J Reprod Immunol. 43: 127-137. 3.011; 48/119; 10;9
89. 1998 Natural killer activating receptors trigger interferon-secretion from T cells and natural killer cells Proc. Natl. Acad. Sci. USA. 95: 3798-3803. 9.598; 3/50; 43;43
90. 1997 The binding site of NK receptors on HLA-C molecules Immunity. 6: 341-350, 19.266; 4/119; 62;57
91. 1997 Self and viral peptides can initiate lysis by autologous NK cells. Proc. Natl. Acad. Sci. USA. 94: 4604-4609. 9.598; 3/50; 34;30
92. 1997 Multiple receptors for HLA-G on human natural killer cells Proc. Natl. Acad. Sci. USA. 94: 14666-14670. 9.598; 3/50; 62;56
93. 1997 Impaired spontaneous endocytosis of HLA-G Eur J. Immunol. 27: 2714-2719. 4.662; 19/119; 38;29
94. 1997 Natural Killer cell lines kill autologous 2-microglobulin-deficient melanoma cells: Implications for cancer immunotherapy Proc. Natl. Acad. Sci. USA 94: 13140-13145. 9.598; 3/50; 63;52
95. 1997 Identification of shared tumor associated antigen peptides between two spontaneous lung carcinoma J. Immunol. 159: 6030-6036. 6.068; 13/119; 16;16
96. 1997 Human NK cells: their ligands, receptors and function Immunol Rev. 155: 119-125, 10.536; 6/119; 66;66
97. 1997 The class I MHC homologue of human cytomegalovirus inhibits Natural Killer cell attack Nature. 386: 514-517, 28.751; 1/50; 209;206
98. 1996 Protection from natural killer cell-mediated lysis by HLA-G expression on target cells Science. 274: 792-795. 26.372; 2/50; 249;239
99. 1996 Enhancement of class II restricted T cell responses by costimulatory NK receptors for MHC class I proteins Science. 274: 2097-2100. 26.372; 2/50; 79;73
100. 1996 Protection from lysis by NK cells of group 1 and group 2 specificity is mediated by residue 80 in HLA-C alleles and also occurs with 'empty' MHC molecules. J. Exp. Med. 184: 913-922. 15.612; 5/119; 147;104
101. 1995 Expression of two H-2K genes, syngeneic and allogeneic as a strategy for potentiating immune recognition of tumor cells Gene Therapy. 2: 757-765, 4.812; 52/263; 18;18
102. 1995 Regression of established murine carcinoma metastases following vaccination with tumor associated antigen peptides Nature Medicine. 1: 1179-1183, 26.382; 3/263; 106;103
103. 1994 CTL induction by a tumor associated antigen octapeptide derived from a murine lung carcinoma Nature. 369: 67-71, 28.751; 1/50; 205; 201. 223;217
104. 1992 Genes and antigens controlling tumor metastasis Rabes, H., Peters, H. and Munk, K. (eds): Metastasis: Basic research and its clinical applications. Contrib. Oncol. Basel, Karger, 44: 1-12
105. 1992 H-2K double transfectants of tumor cells as anti-metastatic cellular vaccines in heterozygous recipients: Implication for T-cell repertoire J. Immunol. 148: 3666-3673, 6.068; 13/119; 20; 17


Biotech China 2014
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.